Cargando…

Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century

Rheumatoid cachexia, loss of muscle mass and strength and concomitant increase in fat mass, is very common in patients with rheumatoid arthritis (RA). Despite great advances in the treatment of RA, it appears that rheumatoid cachexia persists even after joint inflammation improves. Rheumatoid cachex...

Descripción completa

Detalles Bibliográficos
Autor principal: Roubenoff, Ronenn
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688195/
https://www.ncbi.nlm.nih.gov/pubmed/19439037
http://dx.doi.org/10.1186/ar2658
_version_ 1782167672526471168
author Roubenoff, Ronenn
author_facet Roubenoff, Ronenn
author_sort Roubenoff, Ronenn
collection PubMed
description Rheumatoid cachexia, loss of muscle mass and strength and concomitant increase in fat mass, is very common in patients with rheumatoid arthritis (RA). Despite great advances in the treatment of RA, it appears that rheumatoid cachexia persists even after joint inflammation improves. Rheumatoid cachexia may be an important risk factor for cardiovascular disease and excess mortality in RA. In this issue of Arthritis Research & Therapy, Elkan and colleagues demonstrate a link between rheumatoid cachexia and metabolic syndrome, further reinforcing the need for therapy directed beyond inflammation and at the metabolic consequences of RA.
format Text
id pubmed-2688195
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26881952009-05-29 Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century Roubenoff, Ronenn Arthritis Res Ther Editorial Rheumatoid cachexia, loss of muscle mass and strength and concomitant increase in fat mass, is very common in patients with rheumatoid arthritis (RA). Despite great advances in the treatment of RA, it appears that rheumatoid cachexia persists even after joint inflammation improves. Rheumatoid cachexia may be an important risk factor for cardiovascular disease and excess mortality in RA. In this issue of Arthritis Research & Therapy, Elkan and colleagues demonstrate a link between rheumatoid cachexia and metabolic syndrome, further reinforcing the need for therapy directed beyond inflammation and at the metabolic consequences of RA. BioMed Central 2009 2009-04-27 /pmc/articles/PMC2688195/ /pubmed/19439037 http://dx.doi.org/10.1186/ar2658 Text en Copyright © 2009 BioMed Central Ltd
spellingShingle Editorial
Roubenoff, Ronenn
Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
title Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
title_full Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
title_fullStr Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
title_full_unstemmed Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
title_short Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
title_sort rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688195/
https://www.ncbi.nlm.nih.gov/pubmed/19439037
http://dx.doi.org/10.1186/ar2658
work_keys_str_mv AT roubenoffronenn rheumatoidcachexiaacomplicationofrheumatoidarthritismovesintothe21stcentury